L-Sepiapterin

塞匹蝶呤

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameL-Sepiapterin
Drug Alias NameSepiapterine墨蝶蛉SepiapterinSephienceCNSA-001 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhenylalanine hydroxylase activators
TargetsPhenylalanine hydroxylase
Therapy Area/IndicationsPhenylketonuriasGastroparesis
Global Approved IndicationsPhenylketonurias
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2025/06/19
Country/TerritoryCzechiaCanadaUnited States +[22] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesCensa Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPtc Therapeutics IncPtc Therapeutics International LtdTravere Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPhenylketonurias
Inactive IndicationsGastroparesis

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG